Back to Insider Trading View Full Company Profile

MAZE

HEALTHY

Maze Therapeutics, Inc.

CIK: 0001842295

Strong Sell (90% confidence)

Last activity: 1 weeks ago

Financial Metrics

As of Sep 30, 2025 (10-Q)

Net Income -$96.55M
Total Cash $316.77M
Current Ratio 17.70

Insider Roster (4 total, 4 active)

Insider Buys Sells Net Value Holdings
Bernstein Harold
President, R&D & CMO
0 9 -$3.72M
6,036 shares
$277K
Dandekar Atul
CSBO
0 6 -$3.27M
13,303 shares
$586K
Bachrodt Amy
SVP, Finance
0 9 -$1.26M
13,701 shares
$631K
Sohn Catherine A.
OTHER
0 2 -$1.15M
Holdings: -
Value: -

Recent Transactions

SELL Bernstein Harold (President, R&D & CMO)

8,364 shares @ $45.89

$384K

Feb 2, 2026

Conviction: | View SEC Filing →
SELL Bernstein Harold (President, R&D & CMO)

5,936 shares @ $46.37

$275K

Feb 2, 2026

Conviction: | View SEC Filing →
SELL Bachrodt Amy (SVP, Finance)

4,064 shares @ $46.03

$187K

Feb 2, 2026

Conviction: | View SEC Filing →
SELL Bachrodt Amy (SVP, Finance)

736 shares @ $46.63

$34K

Feb 2, 2026

Conviction: | View SEC Filing →
SELL Bernstein Harold (President, R&D & CMO)

600 shares @ $44.20

$27K

Feb 2, 2026

Conviction: | View SEC Filing →
SELL Bachrodt Amy (SVP, Finance)

200 shares @ $44.15

$9K

Feb 2, 2026

Conviction: | View SEC Filing →
SELL Bernstein Harold (President, R&D & CMO)

100 shares @ $47.23

$5K

Feb 2, 2026

Conviction: | View SEC Filing →
SELL Dandekar Atul (CSBO)

3,500 shares @ $44.04

$154K

Jan 29, 2026

Conviction: | View SEC Filing →
SELL Dandekar Atul (CSBO)

2,800 shares @ $45.01

$126K

Jan 29, 2026

Conviction: | View SEC Filing →
SELL Dandekar Atul (CSBO)

1,200 shares @ $43.18

$52K

Jan 29, 2026

Conviction: | View SEC Filing →
SELL Bachrodt Amy (SVP, Finance)

5,000 shares @ $45.52

$228K

Jan 22, 2026

Conviction: | View SEC Filing →
SELL Sohn Catherine A. (OTHER)

26,920 shares @ $39.11

$1.05M

Jan 7, 2026

Conviction: | View SEC Filing →
SELL Bernstein Harold (President, R&D & CMO)

25,156 shares @ $40.20

$1.01M

Jan 7, 2026

Conviction: | View SEC Filing →
SELL Sohn Catherine A. (OTHER)

2,493 shares @ $38.62

$96K

Jan 6, 2026

Conviction: | View SEC Filing →
SELL Bernstein Harold (President, R&D & CMO)

412 shares @ $40.00

$16K

Jan 5, 2026

Conviction: | View SEC Filing →
SELL Bernstein Harold (President, R&D & CMO)

4,432 shares @ $40.43

$179K

Jan 2, 2026

Conviction: | View SEC Filing →
SELL Bachrodt Amy (SVP, Finance)

2,595 shares @ $39.57

$103K

Jan 2, 2026

Conviction: | View SEC Filing →
SELL Bachrodt Amy (SVP, Finance)

2,405 shares @ $38.70

$93K

Jan 2, 2026

Conviction: | View SEC Filing →
SELL Bachrodt Amy (SVP, Finance)

5,000 shares @ $40.08

$200K

Dec 30, 2025

Conviction: | View SEC Filing →
SELL Dandekar Atul (CSBO)

100 shares @ $40.36

$4K

Dec 30, 2025

Conviction: | View SEC Filing →
SELL Dandekar Atul (CSBO)

66,365 shares @ $40.51

$2.69M

Dec 29, 2025

Conviction: | View SEC Filing →
SELL Bernstein Harold (President, R&D & CMO)

27,800 shares @ $40.34

$1.12M

Dec 29, 2025

Conviction: | View SEC Filing →
SELL Bernstein Harold (President, R&D & CMO)

17,200 shares @ $40.93

$704K

Dec 29, 2025

Conviction: | View SEC Filing →
SELL Bachrodt Amy (SVP, Finance)

9,400 shares @ $40.54

$381K

Dec 29, 2025

Conviction: | View SEC Filing →
SELL Dandekar Atul (CSBO)

6,035 shares @ $41.13

$248K

Dec 29, 2025

Conviction: | View SEC Filing →
SELL Bachrodt Amy (SVP, Finance)

600 shares @ $41.16

$25K

Dec 29, 2025

Conviction: | View SEC Filing →

⚠️ Important Disclaimer

• This is AI-generated analysis for educational purposes only, not financial advice.

• Insider trading data is derived from SEC Form 4 filings and may contain errors.

• Always conduct your own research and consult qualified financial advisors before making investment decisions.